Black Diamond Therapeutics, Inc.
NEWS
Biopharma and life sciences companies strengthen their leadership teams and boards with these Movers & Shakers.
Tangles of toxic proteins are associated with various dementias, such as Alzheimer’s disease. Often, these tangles are misfolded proteins. Now, researchers have identified a new mechanism that might reverse the build-up of these aggregates.
The first quarter hasn’t been kind to international biopharmaceutical firms. BioSpace takes a look at the fates of Saniona and Black Diamond below.
AstraZeneca and Daiichi Sankyo reported that their supplemental Biologics License Application (sBLA) for Enhertu was granted Priority Review by the U.S. Food and Drug Administration.
Biopharma and life sciences companies strengthen their leadership teams and boards with these Movers & Shakers.
Heading into the middle of January, companies announced plenty of new clinical trial news. Here’s a look.
It was another busy week for clinical trial announcement. Here’s a look.
Biopharma and life sciences companies strengthen their leadership teams and boards with these Movers & Shakers.
Biopharma and life sciences companies bolster their leadership teams and boards with these Movers & Shakers.
JOBS
IN THE PRESS